Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2383-2393

  Syed, Faisal M ^a   Khan, Masood A ^a   Nasti, Tahseen H ^a   Ahmad, Nadeem ^b   Mohammad, Owais ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Cellular immunity; Cytotoxic T lymphocytes; Escheriosomes; Fusogenic lipids; Vaccine

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LIPOSOME;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HELPER CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOASSAY; LYMPHOCYTE PROLIFERATION; MEMBRANE FUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TARGET CELL;

EID: 0038740885     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00106-3     Document Type: Article

References (37)

1. Agrewala J.N., Owais M., Gupta C.M., Mishra G.C. Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells. Cytokines Mol. Ther. 2:1996;59-65.
2. + T lymphocytes specific for an epitope of 16 kDa α crystalline antigen of mycobacterium tuberculosis. Eur. J. Immunol. 28:1998;1753-1761.
3. Braciale T.J., Morrison L.A., Sweetser M.T., Sambrook J., Gething M.J., Braciale V.L. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98:1987;95-114.
4. Liebana E., Girvin R.M., Welsh M., Niell s, Pallock J.M. Generation of CD8+ T cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect. Immun. 67:1999;1034-1044.
5. Unanue E.R., Allen P.M. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 236:1987;551-557.
6. Nickell S.P., Stryker G.A., Arevalo C. Isolation from Trypanosoma crusi infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite infected target cells. J. Immunol. 150:1993;1446-1457.
7. Muller I., Redrazzine T., Krlopf P., Louis J., Millon G. Establishment of resistance to Leishmania major infection in susceptible balb/c mice requires parasite specific CD8+ T cells. Int. Immunol. 3:1991;587-597.
8. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., Bloom B.R. Major histocompatibility complex class I restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA. 89:1992;12013-12017.
9. Deres K., Schild H., Wiesmuller K.H., Jung G., Rammensee H.G. In vivo priming of virus specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature. 342:1989;561-564.
10. Tarleton R.L., Koller B.H., Latour A., Paston M. Susceptibility of β2-microglobulin deficient mice to Trypanosoma cruzi infection. Nature. 365:1992;338-340.
11. Bottomly K.A. A functional dichotomy in CD4+ T lymphocytes. Immunol. Today. 9:1988;268-274.
12. Voet D, Voet JG, Pratt CW. In: Cliff M, editor. Fundamentals of biochemistry. New York: Wiley; 1999. p. 239-78.
13. White J.M. Membrane fusion. Science. 258:1992;917-924.
14. Krishnan L., Dicaire C.J., Patel G.B., Sprott G.D. Archeosome vaccine adjuvants induce strong humoral. Infect. Immun. 68:2000;54-63.
15. Conlan J.W., Krishnan L., Willick G.E., Patel G.B., Sprott G.D. Immunization of mice with lipopeptide antigen encapsulated in novel liposomes prepared from polar lipids of various archaebacteria elicits rapid and prolonged specific immunity against infection with the faculattive intracellular pathogen, Lysteria monocytogenes. Vaccine. 19:2001;3509-3517.
16. Rattray JBM. In: Ratledge C, Wilkinson SG, editors. Microbial lipids, vol. 1. London: Academic Press. p. 555-97.
17. Owais M., Gupta C.M. Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development. Eur. J. Biochem. 267:2000;3946-3956.
18. Ahmad N., Masood A.K., Owais M. Fusogenic potential of prokaryotic membrane lipids: implication in vaccine development. Eur. J. Biochem. 268:2001;5667-5675.
19. Stevens T.L., Bossie A., Sanders V.M., Fernandez B.R., Coffman R.L., Mosmann T.R.et al. Regulation of antibody isotype secretion by subset of antigen specific helper T cells. Nature. 334:1988;2525-2528.
20. Shaji A.V., Kulkarni M.Y., Agrewala J.N. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin specific T cells. Clin. Exp. Immunol. 111:1998;181-185.
21. Singleton W.S., Gray M.S., Brown M.L. A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions. J. Am. Oil. Chem. Soc. 42:1965;53-56.
22. Mishell BB, Shiigi SM. Selected methods in cellular immunology. New York: Freeman; 1980. p. 23-4.
23. Agrewala J.N., Sumit S., Verma R.K., Mishra G.C. Differential effect of anti-B7.1 and anti M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages. J. Immunol. 160:1998;1067-1077.
24. Malik A., Gross M., Ulrich T., Hoffman S.L. Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant. Infect. Immun. 61:1993;5062-5066.
25. Sasiain M.C., de la Barrera S., Fink S., Finiasz M., Aleman M., Farina M.H.et al. Interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4+ and CD8+ cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kDa. Clin. Exp. Immunol. 114:1998;193-196.
26. Audibert F.M., Lise L.D. Adjuvants: current status. Immunol. Today. 14:1993;281-284.
27. Leclerc C., Ronco J. New approaches in vaccine development. Immunol. Today. 19:1998;300-302.
28. Mandal M., Lee K.D. Lysteriolysin O-liposome mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Biochem. Biophys. Acta. 1563:2002;7-17.
29. Polt-Frank F., Zurbriggen R., Helg A., Stuart F., Robinson J., Gluck R.et al. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine. Clin. Exp. Immunol. 117:1999;496-503.
30. Lee K.Y., Chun E., Seong B.L. Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH sensitive liposomes encapsulated with K(b)-restricted CTL epitope. Biochem. Biophys. Res. Commun. 292(3):2002;682-688.
31. Kunisawa T., Nakagawa S., Mayumi T. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv. Drug Deliv. Rev. 52:2001;177-186.
32. Babai I., Barenholz Y., Zakay-Rones Z., Greenbaum E., Samira S., Hayon I.et al. A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains. Vaccine. 20:2002;505-515.
33. Harding C.V., Collins D.S., Kanangawa O., Kanagawa O., Unanue E.R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147:1991;2860-2863.
34. Gerosa F., Paganin C., Peritt D., Paiola F., Scupoli M.T., Amezaga M.A.et al. Interleukin-12 primes human CD4+ and CD8+ T cell clones for high production of both interferon γ and interleukin-10. J. Exp. Med. 183:1996;2559-2569.
35. Siegrist C.A., Plotnicky-Gilquin H., Cordova M., Berney M., Bonnefoy J.Y., Nguyen T.N.et al. Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies. J. Infect. Dis. 179:1999;1326-1333.
36. + T-cell responses in mice homozygous for disruption of the interleukin-4 gene. J. Virol. 71:1997;2518-2521.
37. Owais M., Khan M.A., Agrewala J.N., Bisht D., Gupta C.M. Use of liposomes as an immunopotentiating delivery system: in perspective of vaccine development. Scand. J. Immunol. 54:2001;1-9.